Cencora, Inc. (COR)
NYSE: COR · Real-Time Price · USD
339.66
+2.03 (0.60%)
At close: Dec 5, 2025, 4:00 PM EST
339.95
+0.29 (0.09%)
After-hours: Dec 5, 2025, 7:57 PM EST
Cencora Employees
Cencora had 51,000 employees as of September 30, 2025. The number of employees increased by 5,000 or 10.87% compared to the previous year.
Employees
51,000
Change (1Y)
5,000
Growth (1Y)
10.87%
Revenue / Employee
$6,300,644
Profits / Employee
$30,474
Market Cap
65.89B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Sep 30, 2025 | 51,000 | 5,000 | 10.87% |
| Sep 30, 2024 | 46,000 | 0 | - |
| Sep 30, 2023 | 46,000 | 2,000 | 4.55% |
| Sep 30, 2022 | 44,000 | 2,000 | 4.76% |
| Sep 30, 2021 | 42,000 | 20,000 | 90.91% |
| Sep 30, 2020 | 22,000 | 0 | - |
| Sep 30, 2019 | 22,000 | 1,000 | 4.76% |
| Sep 30, 2018 | 21,000 | 1,000 | 5.00% |
| Sep 30, 2017 | 20,000 | 1,000 | 5.26% |
| Sep 30, 2016 | 19,000 | 1,500 | 8.57% |
| Sep 30, 2015 | 17,500 | 3,500 | 25.00% |
| Sep 30, 2014 | 14,000 | 1,000 | 7.69% |
| Sep 30, 2013 | 13,000 | -1,500 | -10.34% |
| Sep 30, 2012 | 14,500 | 4,200 | 40.78% |
| Sep 30, 2011 | 10,300 | 300 | 3.00% |
| Sep 30, 2010 | 10,000 | -300 | -2.91% |
| Sep 30, 2009 | 10,300 | -600 | -5.50% |
| Sep 30, 2008 | 10,900 | -400 | -3.54% |
| Sep 30, 2007 | 11,300 | -3,400 | -23.13% |
| Sep 30, 2006 | 14,700 | 1,300 | 9.70% |
| Sep 30, 2005 | 13,400 | -700 | -4.96% |
| Sep 30, 2004 | 14,100 | -700 | -4.73% |
| Sep 30, 2003 | 14,800 | 1,100 | 8.03% |
| Sep 30, 2002 | 13,700 | 0 | - |
| Sep 30, 2001 | 13,700 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
COR News
- 2 days ago - Cencora Enhances Global Pharmaceutical Logistics Services, Cold Chain Capabilities - Business Wire
- 3 days ago - Cencora, Inc. (COR) Presents at Citi Annual Global Healthcare Conference 2025 Transcript - Seeking Alpha
- 3 days ago - Cencora, Inc. (COR) Presents at Evercore 8th Annual Healthcare Conference Transcript - Seeking Alpha
- 4 weeks ago - Cencora: Earnings Visibility Driving Re-Rating Potential - Seeking Alpha
- 4 weeks ago - Cencora, Inc. (COR) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Cencora to invest $1 billion on US drug distribution, posts upbeat 2026 forecast - Reuters
- 4 weeks ago - Drug Distributor Cencora to Invest $1 Billion in U.S. Supply Chain - WSJ
- 4 weeks ago - Cencora Announces $1 Billion Investment to Strengthen Its U.S. Distribution Network - Business Wire